Lars Fruergaard Jørgensen removed as CEO of Novo Nordisk

According to a “mutual agreement” between board members of the global healthcare company Novo Nordisk, Lars Fruergaard Jørgensen will step down from his position as CEO. He was appointed at this position since January 2017

Photo: Novo Nordisk
Novo Nordisk, Lars Fruergaard Jørgensen has been the Chief Executive Officer since 2017

Novo Nordisk, Lars Fruergaard Jørgensen will step down from his position as Chief Executive Officer (CEO). He has been in this position since January 2017. The decision was taken after a “mutual agreement” between board members of the pharmaceutical company, and announced in a press release.The Novo Nordisk Board, along with the Novo Nordisk Foundation […]


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?